NYSE · NKE

Nike, Inc.

$42.14 +$0.44 (+1.06%) 1D After hours
Session Pulse Overnight session 1 mentions on Fri · 1 bullish / 0 bearish tags No new SEC filings since Mon close its sector ranked 7/11 this week Full pulse →
Charting by TradingView

Key Metrics

$61.86B
Market cap
27.49×
P/E · TTM
$46.52B
Revenue · TTM
$2.25B
Net income
EPS · TTM $1.52
Dividend yield 3.9%
Free cash flow $1.05B
Beta · 1Y 0.85
EBITDA · TTM $3.27B
Gross margin 40.8%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 26
    From its Feb 19 high, the share price fell 38%.

    Peak close $65.61 on Feb 19; trough close $40.75 on Jun 26. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -38%
  • Apr 1
    The stock moved -15.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 1

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$61.86B
Enterprise value$63.23B
Shares outstanding1.5B
52-wk range$40.00 – $80.17
Avg volume · 20D11.0M
Net cash −$1.37B
Book value / share$9.52
IndustryRubber & Plastics Footwear
ExchangeNYSE
About Nike, Inc.
IPO dateDec 2, 1980
Employees73000

Nike is the largest athletic footwear and apparel brand in the world. Footwear generates about two-thirds of its sales. Key performance footwear categories include basketball, running, and football (soccer).

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E27.49
P/S1.33
P/FCF59.03
EV/EBITDA19.32
EV/Sales1.36
Graham №$18.04

Profitability

Gross 40.8%
Operating 6.2%
Net 4.8%
FCF 2.3%
ROE / ROIC 15.8% · 14.6%

Financial Health

Current ratio2.14
Quick ratio—
Debt / equity0.57
Debt / EBITDA 2.45
Net cash −$1.37B
Working capital$12.35B

Cash Flow · TTM

Operating CF $1.69B
Capex −$646.00M
Free cash flow $1.05B
Buybacks $345.00M
Dividends paid $2.39B
Shareholder yield 4.4%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

—
Insufficient balance-sheet inputs

Graham Number vs Price

$18.04 vs $42.14
Trades 2.3× above classic defensive value — priced for growth
Fundamentals through 2026-02-28 · computed by TickerWolf from SEC filings